2021

1. Early clinical experience with trifluridine/tipiracil for refractory metastatic colorectal cancer: The ros study

   Cancers, Vol. 13, Núm. 18

2. Patient profiles as an aim to optimize selection in the second line setting: the role of aflibercept

   Clinical and Translational Oncology, Vol. 23, Núm. 8, pp. 1520-1528